Merck sells Pithiviers plant to Orgasynth
In a move to consolidate its global production infrastructure, Merck KGaA is selling its production site in Pithiviers, France, to Orgasynth, a Paris-based chemical company specialising in the production of fine chemicals and intermediates.
In a move to consolidate its global production infrastructure, Merck KGaA is selling its production site in Pithiviers, France, to Orgasynth, a Paris-based chemical company specialising in the production of fine chemicals and intermediates.
Under terms of the agreement, Orgasynth will take over the production site including all assets and liabilities. Of the total 94 employees, 77 will transfer to Orgasynth, while the remaining 17 will either retire or have accepted an offer of early retirement. In addition, Orgasynth will take over the existing business and continue to produce for Merck.
Established in 1973 by Anphar Rolland Laboratories, the Pithiviers site focuses on development and production of finished products, intermediates and active pharmaceutical ingredients used by several businesses of Merck.
'With this move, we further optimise our global production network to remain competitive and we are able to secure employment for the majority of employees,' said Elmar Schnee, president of Merck Sante in France.